Ildong Pharmaceutical said that Japan's Ministry of Health, Labour and Welfare has granted emergency use approval (EUA) for Shionogi & Co's Xocova, an oral Covid-19 treatment Ildong has been co-developing.Shionogi applied for conditional approval for Xocova to Japan's Ministry of Health, Labor and W